{"id":"https://openalex.org/A5145200210","orcid":null,"observed_orcids":[],"display_name":"Madina Tleugabyl","raw_author_names":["Madina Tleugabyl","Tleugabyl, Madina"],"full_name":"Madina Tleugabyl","works_count":1,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5145200210","orcid":null,"observed_orcids":[]},"affiliations":[],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":1,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","count":1,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","value":8e-06,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","value":3.9e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","value":2.3e-06,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","score":0.7056999802589417},{"id":"119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","score":0.4821999967098236},{"id":"133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","score":0.37389999628067017},{"id":"110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","score":0.2775000035762787},{"id":"168785527","wikidata":"https://www.wikidata.org/wiki/Q1401099","display_name":"Solute carrier family","score":0.25450000166893005}],"counts_by_year":[{"year":2022,"works_count":1,"oa_works_count":0,"cited_by_count":0}],"display_name_alternatives":["Madina Tleugabyl","Tleugabyl, Madina"],"block_key":"m tleugabyl","works_api_url":"https://api.openalex.org/works?filter=author.id:A5145200210","updated_date":"2026-10-05T12:30:24","created_date":"2026-08-07T00:00:00"}